•   
  •   
  •   

US U.S. allotting 85% less J&J vaccines to states next week, data shows

11:15  08 april  2021
11:15  08 april  2021 Source:   reuters.com

Music festivals, Opening Day, casino clinics: News from around our 50 states

  Music festivals, Opening Day, casino clinics: News from around our 50 states How the COVID-19 pandemic is affecting every stateStart the day smarter. Get all the news you need in your inbox each morning.

(Reuters) - The U.S. government will allot nearly 85% less Johnson & Johnson COVID-19 vaccines to states next week, data from Centers for Disease Control and Prevention (CDC) showed.

a hand holding a blue object: FILE PHOTO: A nurse draws from a vial of Johnson & Johnson coronavirus disease (COVID-19) vaccine, in Los Angeles © Reuters/LUCY NICHOLSON FILE PHOTO: A nurse draws from a vial of Johnson & Johnson coronavirus disease (COVID-19) vaccine, in Los Angeles

Only 785,500 J&J doses will be allocated, compared to 4.95 million doses this week. The U.S. Department of Health and Human Services (HHS) and J&J did not immediately respond to requests, made outside regular hours, for comment on the drop in numbers.

A New York Times report last week said that workers at an Emergent BioSolutions facility in Baltimore, which produced both AstraZeneca Plc and J&J doses, mixed up ingredients of the two vaccines, ruining 15 million J&J doses.

Official: Chinese vaccines' effectiveness low

  Official: Chinese vaccines' effectiveness low BEIJING (AP) — In a rare admission of the weakness of Chinese coronavirus vaccines, the country's top disease control official says their effectiveness is low and the government is considering mixing them to get a boost. Chinese vaccines “don’t have very high protection rates,” said the director of the China Centers for Disease Control, Gao Fu, at a conference Saturday in the southwestern city of Chengdu. Beijing has distributed hundreds of millions of doses abroad while trying to promote doubt about the effectiveness of the Pfizer-BioNTech vaccine made using the previously experimental messenger RNA, or mRNA, process.

However, the Baltimore facility has not yet been authorized by the U.S. Food and Drug Administration, and a federal health official told Reuters last week that none of the vaccine doses from the plant have been used in vaccination efforts so far.

J&J has reiterated that it expected to deliver 100 million doses to the government by the end of May.

According to the CDC data, California is the main recipient of the J&J vaccine, followed by Texas and Florida. The vaccine allocation for California is down by about 88%, with the state set to receive only a maximum of 67,600 doses next week.

A California health official told Reuters that the number will be down further in the week starting April 18, with only 22,400 doses of the J&J vaccine allocated to the state.

U.S. President Joe Biden on Tuesday moved up the COVID-19 vaccine eligibility target for all American adults to April 19.

(Reporting by Shubham Kalia and Aakriti Bhalla in Bengaluru; Editing by Simon Cameron-Moore)

Chinese Covid-19 vaccine efficacy is 'not high,' top health official admits .
The efficacy of Chinese Covid-19 vaccines is "not high" and authorities are weighing options to bolster protection -- including mixing different shots, China's top disease control official has said. © AP Gao Fu, director of the Chinese Center for Disease Control and Prevention, speaks at the National Vaccines and Health conference in Chengdu, Sichuan province Saturday. "The protection rates of existing vaccines are not high," Gao Fu, director of the Chinese Center for Disease Control and Prevention, told a conference in the southwestern city of Chengdu on Saturday.

usr: 1
This is interesting!